Abstracts - faqs.org

Abstracts

Education

Search abstracts:
Abstracts » Education

Medical college's claims under fire

Article Abstract:

The Trading Standards Service has been called in by the Department for Education and Skills to investigate the Medical College of London (MCL), a private medical college, after it was discovered that the college had made incorrect claims to have been "affiliated" with King's College London (KCL) and the University of Greenwich (UoG) and that it had wrongly cited Greenwich's Anson Building, on its Medway Maritime Campus in Kent, as its business address and HQ. Both KCL and UoG acknowledge that the have accepted payments from MCL for the provision of teaching, but they both insist that MCL has exaggerated its links to them without permission.

Author: Baty, Phil
Publisher: Times Supplements Ltd.
Publication Name: Times Higher Education Supplement
Subject: Education
ISSN: 0049-3929
Year: 2003
United Kingdom. Department for Education and Skills

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Medical college kicked off campus

Article Abstract:

Greenwich University has severed its ties with the Medical College of London (MCL), a private institution, after questions were raised about the latter's credentials. It has come to light that MCL is linked to Daniel Harrington, a US businessman who agreed a payout in 2000 to three students that he had signed up to medical degrees that were deemed by Hardy Myers, the attorney-general of Oregon, to be "worthless". Solicitors for MCL claim that the college offers "recognised medical qualifications"

Author: Baty, Phil
Publisher: Times Supplements Ltd.
Publication Name: Times Higher Education Supplement
Subject: Education
ISSN: 0049-3929
Year: 2003
Services information, Alliances, partnerships, Services, Alliances and partnerships, Greenwich University

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Experts cast doubt over scientists' claims for Actonel

Article Abstract:

Doubts over scientific claims about Procter & Gamble's Actonel osteoperosis drug have been raised after a report by The Times Higher that Sheffield University researchers put their names to findings without conducting independent analyses of the drug trial data. Experts argue that there is not enough evidence to warrant conclusions on Actonel which were published by the Bone Metabolism Research Unit of Sheffield University.

Author: Baty, Phil
Publisher: Times Supplements Ltd.
Publication Name: Times Higher Education Supplement
Subject: Education
ISSN: 0049-3929
Year: 2006
Product development, Product standards, safety, & recalls, Science & research, Research and Testing Services, Scientific Research and Development Services, Soap and Other Detergent Manufacturing, Soap, Cleaners, and Toilet Goods, Soaps & Detergents, Research & Development-Universities, Standards, Research, Universities and colleges, Procter & Gamble Co., Soap and cleaning agents industry, Cleaning agents industry, University research, University of Sheffield

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, Company legal issue, Cases, Investigations, Medical colleges, Medical schools, Medical College of London
Similar abstracts:
  • Abstracts: Controversial Cardiff keeps it in the family. Marks U-turn is 'mockery of exam process'. College heads criticise AoC selection process
  • Abstracts: Serial killer halted by headlines and hype. Scare tactics silence science. When fear becomes another epidemic
  • Abstracts: UK failing to prepare for tide of foreigners. Colleges fail to fill third of foundation courses
  • Abstracts: Manager 'rewrote history' for QAA bid. When firing off can get you fired..
  • Abstracts: Academic claims Seoul credit for others' work. 'Everyone is a loser in a misconduct case'. Academic who spoke out now faces sack
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.